(E)-6-Chloro-2-(4-nitrostyryl)-4-(1-piperidinylethyl)aminoquinazoline

ID: ALA4764913

PubChem CID: 162661709

Max Phase: Preclinical

Molecular Formula: C23H24ClN5O2

Molecular Weight: 437.93

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])c1ccc(/C=C/c2nc(NCCN3CCCCC3)c3cc(Cl)ccc3n2)cc1

Standard InChI:  InChI=1S/C23H24ClN5O2/c24-18-7-10-21-20(16-18)23(25-12-15-28-13-2-1-3-14-28)27-22(26-21)11-6-17-4-8-19(9-5-17)29(30)31/h4-11,16H,1-3,12-15H2,(H,25,26,27)/b11-6+

Standard InChI Key:  PPSBBIUJXBCPJK-IZZDOVSWSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   12.9540   -4.8164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9528   -5.6360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6609   -6.0449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6591   -4.4076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3677   -4.8128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3684   -5.6319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0770   -6.0389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7852   -5.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7805   -4.8060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0714   -4.4026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4945   -6.0339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2006   -5.6226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9099   -6.0284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9085   -6.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6169   -7.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3240   -6.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3182   -6.0170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6092   -5.6149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0671   -3.5854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7726   -3.1731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4825   -3.5779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1880   -3.1656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8965   -3.5747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5999   -3.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5998   -2.3483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8901   -1.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1805   -2.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0341   -7.2431    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7397   -6.8309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0384   -8.0603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2461   -4.4080    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 10 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 28 29  2  0
 28 30  1  0
 16 28  1  0
  1 31  1  0
M  CHG  2  28   1  30  -1
M  END

Alternative Forms

  1. Parent:

    ALA4764913

    ---

Associated Targets(Human)

T-24 (2342 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 437.93Molecular Weight (Monoisotopic): 437.1619AlogP: 5.26#Rotatable Bonds: 7
Polar Surface Area: 84.19Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.72CX LogP: 6.04CX LogD: 4.70
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.40Np Likeness Score: -1.46

References

1. Wei XW,Yuan JM,Huang WY,Chen NY,Li XJ,Pan CX,Mo DL,Su GF.  (2020)  2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.,  186  [PMID:31761381] [10.1016/j.ejmech.2019.111851]

Source